First In-Human Trial of Crispr Shown to Safely Lower Cholesterol
Postedabout 2 months ago
newsroom.clevelandclinic.orgResearchstory
calmpositive
Debate
0/100
CrisprGene EditingCholesterol Reduction
Key topics
Crispr
Gene Editing
Cholesterol Reduction
Cleveland Clinic's first-in-human trial of CRISPR gene editing therapy has shown to safely lower cholesterol and triglycerides, marking a potential breakthrough in genetic treatment.
Snapshot generated from the HN discussion
Discussion Activity
No activity data yet
We're still syncing comments from Hacker News.
Generating AI Summary...
Analyzing up to 500 comments to identify key contributors and discussion patterns
ID: 45876025Type: storyLast synced: 11/17/2025, 5:59:21 AM
Want the full context?
Jump to the original sources
Read the primary article or dive into the live Hacker News thread when you're ready.
Discussion hasn't started yet.